Seeking Alpha

Genmab A/S (GNMSF)

- Grey Market
  • EP Vantage | Send Message 1 Jun

    Asco - A Sirius Lead For Daratumumab $GMXAY, $GNMSF
      GNMSF vs. ETF Alternatives
      Company Description
      Genmab is an international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer.
      Sector: Technology
      Industry: Biotechnology
      Country: Denmark